Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines

BACKGROUND & AIMS: It is estimated that 3.26 million children and adolescents worldwide have chronic HCV infection. To date, the global response has focused on the adult population, but direct-acting antiviral (DAA) regimens are now approved for children aged ≥3 years. This global review describ...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Farihah, Bailey, Heather, Chan, Polin, Collins, Intira Jeannie, Mozalevskis, Antons, Thorne, Claire, Easterbrook, Philippa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898178/
https://www.ncbi.nlm.nih.gov/pubmed/33665586
http://dx.doi.org/10.1016/j.jhepr.2021.100227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898178/
https://www.ncbi.nlm.nih.gov/pubmed/33665586
http://dx.doi.org/10.1016/j.jhepr.2021.100227

Ejemplares similares